MINNEAPOLIS, Feb. 4, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 31 ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has ...

Hollow Brook Wealth Management sold its entire position in Bio-Techne -- 174,677 shares -- during the fourth quarter of 2025, for an estimated $10.7 million based on quarterly average pricing. The ...

Shares of Bio-Techne Corp. TECH advanced 1.43% to $47.37 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.17% to 7,445.72 ...

Life sciences company Bio-Techne (NASDAQ:TECH) fell short of the market’s revenue expectations in Q1 CY2026, with sales falling 1.5% year on year to $311.4 million. Its non-GAAP profit of $0.53 per ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Shares of Bio-Techne Corp. slid 5.34% to $44.89 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.58% to 7,444.25 and the Dow ...

RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, ...